Zacks Investment Research on MSN
Three best genomics stocks for your portfolio in 2026
An updated edition of the Feb. 20, 2026, article. Genomics involves a thorough study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). It involves understanding how genes ...
On a conference call with analysts, Gilead walked through how a string of recent deals focused on cancer and autoimmune ...
Lunsekimig, a bispecific drug aimed at two popular targets, succeeded in studies in asthma and nasal polyps but missed its mark in an eczema trial.
Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for osteoarthritis, today announced its formal launch from stealth mode and collaboration with ...
Leading fitness brand Les Mills today announces the global launch of RISE: Search for the Ultimate Trainers, a new YouTube docuseries that takes viewers behind the scenes of elite performance at the ...
Organon has been on Sun Pharma's radar for some time, but a more serious evaluation began towards the end of November last ...
Deloitte has noted that digital transformation in life sciences manufacturing can boost operational efficiency by streamlining processes, increasing productivity and reducing errors. AI systems can ...
AINewsWire Editorial Coverage: As regulatory expectations intensify and manufacturing complexity grows, pharmaceutical companies are moving beyond traditional quality systems toward a new paradigm: ...
Packaging giant Orora (ASX:ORA) plunged 17% after downgrading earnings and pausing its buyback, blaming the Middle East ...
India’s listing and IPO norms are structurally incompatible with biotechnology innovation, where companies often spend a ...
A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results